
Modafinil is a wakefulness-promoting agent with a unique pharmacologic profile that sets it apart from traditional stimulants. Clinically shown to reduce fatigue and enhance mental alertness — without the drawbacks commonly associated with amphetamine-based medications.
Schedule IV — lower abuse liability
200× less addictive than dextroamphetamine
Preserves natural sleep architecture
No melatonin/cortisol/GH disruption
No withdrawal symptoms in clinical studies
Minimal peripheral effects at prescribed doses
Unique hippocampus/thalamus pathway
40 weeks continuous efficacy, no tolerance
Schedule II — higher abuse liability
Higher potential for dependence and addiction
Can disrupt sleep patterns and architecture
Affects cortisol and other stress hormones
Withdrawal symptoms upon discontinuation
More pronounced peripheral sympathomimetic effects
Dopamine/norepinephrine reuptake mechanism
Tolerance development may require dose escalation




Modafinil works through entirely different CNS pathways — targeting the hippocampus and thalamus rather than dopamine/norepinephrine reuptake. It's classified Schedule IV (vs Schedule II for Adderall), is 200× less addictive than dextroamphetamine, doesn't disrupt sleep architecture, and has no reported withdrawal symptoms in clinical studies.
Yes — Calming is specifically formulated for rosacea-prone, sensitive skin. All four actives in this formula have established tolerability profiles on reactive skin, and Niacinamide is included specifically to buffer irritation and support barrier function. That said, some patients experience mild transient tingling or temporary redness in the first 1–2 weeks as skin adjusts, particularly with Azelaic Acid. These effects typically resolve with continued use. If you have reactive skin, apply to completely dry skin and start with once-daily use before progressing to twice daily as tolerated.
Modafinil is over 200× less potent than dextroamphetamine in producing addictive behaviors. It's classified as a Schedule IV controlled substance (lower abuse liability than Schedule II stimulants). No specific withdrawal symptoms have been reported upon discontinuation in clinical studies.
Unlike traditional stimulants, Modafinil does not disrupt nocturnal sleep patterns or natural sleep architecture. It does not alter hormones associated with sleep regulation, including melatonin, cortisol, and growth hormone.
Modafinil is available in 100 mg and 200 mg tablet strengths, compounded by Empower Pharmacy's 503A facility. Your provider will determine the appropriate strength based on your diagnosis and clinical needs.
Complete an online medical consultation. A licensed healthcare provider will review your symptoms, medical history, and determine if Modafinil is clinically appropriate for an FDA-approved indication. If prescribed, your order is compounded by Empower Pharmacy and shipped nationwide.
Clinical trials have demonstrated continued efficacy for up to 40 weeks without tolerance development. This is a significant advantage over some traditional stimulant medications where dose escalation may become necessary.
© 2026, TestosteroneShots.com PC
text (323)-283-9219
638 1/2 N Robertson Blvd, West Hollywood, CA 90069

The information and products provided on this website are for informational and wellness purposes only and are not intended to diagnose, treat, cure, or prevent any disease. All medical treatments are subject to evaluation and approval by a licensed healthcare provider through a telemedicine consultation. Individual results may vary, and the use of any product carries potential risks and side effects that should be discussed with a qualified medical professional. These products are not approved by the FDA unless explicitly stated, and misuse or unauthorized sharing is strictly prohibited. By using this site or purchasing any service, you agree to our Terms of Service, Telehealth Consent, and Privacy Policy. We prioritize your privacy and comply with HIPAA regulations for protected health information. Services provided by licensed physicians/nurse practitioners in states served, e.g., CA, FL, and others, via telemedicine. Check your state's telemedicine laws. Must Be 18+ or Older to Qualify For Treatment.